Ⅲ<sub>A</sub>—N<sub>2</sub>期NSCLC治疗争议与进展

doi:10.3760/cma.j.issn.1004-4221.2017.04.023

Abstract
Figure/Table
References()
Related Citation (15)
Read Tracking
Download Tracking

[1] Mountain CF.Revisions in the international system for staging lung cancer[J].Chest,1997,111(6):1710-1717.DOI:10.1378/chest.111.6.1710
[2] 中国抗癌协会肺癌专业委员会.NSCLCⅢ_A期N₂之处理[J].循证医学,2008,8(2):113-117.DOI:10.3969/j.issn.1671-5144.2008.02.014.Lung cancer Specialized Committee of Anti-Cancer Association of China. Treatment of stage Ⅲ_A—N₂ NSCLC[J].Evi-Bas Med,2008,8(2):113-117.DOI:10.3969/j.issn.1671-5144.2008.02.014
[3] Splinter TA,van Schil PE,Kramer GW,et al. Randomized trial of surgery versus radiotherapy in patients with stage Ⅲ_A (N₂) non small-cell lung cancer after a response to induction chemotherapy. EORTC 08941[J].Clin Lung Cancer,2000,2(1):69-72.DOI:10.3816/CLC.2000.n.020
[4] Albain KS,Swann RS,Rusch VW,et al. Radiotherapy plus chemotherapy with or without surgical resection for stage Ⅲ non-small-cell lung cancer:a phase Ⅲ randomised controlled trial[J].Lancet,2009,374(9687):379-386.DOI:10.1016/S0140-6736(09)60737-6
[5] Xu YP,Li B,Xu XL,et al. Is there a survival benefit in patients with stage Ⅲ_A (N₂) Non-small cell lung cancer receiving neoadjuvant chemotherapy and/or radiotherapy prior to surgical resection:a systematic review and meta-analysis[J].Medicine,2015,94(23):e879.DOI:10.1097/MD.0000000000000879
[6] Aggarwal C,Li LN,Borghaei H,et al. Multidisciplinary therapy of stage Ⅲ_A non-small-cell lung cancer:long-term outcome of chemoradiation with or without surgery[J].Cancer Control,2014,21(1):57-62
[7] Van Meerbeeck JP,Kramer GW,Van Schil PEY,et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage Ⅲ_A—N₂ non-small-cell lung cancer[J].J Natl Cancer Inst,2007,99(6):442-450.DOI:10.1093/jnci/djk093
[8] Bakir M,Fraser S,Routledge T,et al. Is surgery indicated in patients with stage Ⅲ_aⅢ lung cancer and mediastinal nodal involvement?[J].Interact Cardiovasc Thorac Surg,2011,13(3):303-310.DOI:10.1510/icvts.2011.267872
[9] Stefani A,Alifano M,Bobbio A,et al. Which patients should be operated on after induction chemotherapy for N₂ non–small cell lung cancer? Analysis of a 7-year experience in 175 patients[J].J Thorac Cardiovasc Surg,2010,140(2):356-363.DOI:10.1016/j.jtcvs.2010.02.018.
[10] Hanagiri T,Takenaka M,Oka S,et al. Clinical significance in the number of involved lymph nodes in patients that underwent surgery for pathological stage Ⅲ-N₂ non-small cell lung cancer[J].J Cardiothorac Surg,2011,6:144.DOI:10.1186/1749-8090-6-144.
[11] NSCLC Meta-Analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer:a systematic review and meta-analysis of individual participant data[J].Lancet,2014,383(9928):1561-1571.DOI:10.1016/S0140-6736(13)62159-5.
[12] Shah AA,Berry MF,Tzao C,et al. Induction chemoradiation is not superior to induction chemotherapy alone in stage Ⅲ_A lung cancer[J].Ann Thorac Surg,2012,93(6):1807-1812.DOI:10.1016/j.athoracsur.2012.03.018.
[13] Sher DJ,Fidler MJ,Liptay MJ,et al. Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage Ⅲ_A non-small cell lung cancer[J].Lung Cancer,2015,88(3):267-274.DOI:10.1016/j.lungcan.2015.03.015.
[14] Pless M,Stupp R,Ris HB,et al. Induction chemoradiation in stage Ⅲ_A/N₂ non-small-cell lung cancer:a phase 3 randomized trial[J].Lancet,2015,386(9998):1049-1056.DOI:10.1016/S0140-6736(15)60294-X.
[15] Thomas M,Rübe C,Hoffknecht P,et al. Effect of preoperative chemoradiation in addition to preoperative chemotherapy:a randomised trial in stage Ⅲ non-small-cell lung cancer[J].Lancet Oncol,2008,9(7):636-648.DOI:10.1016/S1470-2045(08)70156-6.
[16] Pezzetta E,Stupp R,Zouhair A,et al. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage Ⅲ(N₂) NSCLC[J].Eur J Cardiothorac Surg,2005,27(6):1092-1098.DOI:10.1016/j.ejcts.2005.02.035.
[17] Higgins K,Chino JP,Marks LB,et al. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage Ⅲ(N₂) non-small-cell lung cancer[J].Int J Radiat Oncol Biol Phys,2009,75(5):1462-1467.DOI:10.1016/j.ijrobp.2009.01.069.
[18] Girard N,Mornex F,Douillard JY,et al. Is neoadjuvant chemoradiotherapy a feasible strategy for stage Ⅲ_A—N₂ non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase Ⅱ trial[J].Lung Cancer,2010,69(1):86-93.DOI:10.1016/j.lungcan.2009.10.003.
[19] Katakami N,Tada H,Mitsudomi T,et al. A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N₂ stage Ⅲ_A nonsmall cell lung cancer (WJTOG9903)[J].Cancer,2012,118(24):6126-6135.DOI:10.1002/cncr.26689.
[20] Lally BE,Zelterman D,Colasanto JM,et al. Postoperative radiotherapy for stage Ⅱ or Ⅲ non-small-cell lung cancer using the surveillance,epidemiology,and end results database[J].J Clin Oncol,2006,24(19):2998-3006.DOI:10.1200/JCO.2005.04.6110.
[21] Douillard JY,Rosell R,De Lena M,et al. Impact of postoperative radiation therapy on survival in patients with complete resection and stage Ⅰ,Ⅱ,or Ⅲ_A non-small-cell lung cancer treated with adjuvant chemotherapy:the adjuvant navelbine international Trialist Association (ANITA) randomized trial[J].Int J Radiat Oncol Biol Phys,2008,72(3):695-701.DOI:10.1016/j.ijrobp.2008.01.044.
[22] Kim BH,Kim HJ,Wu HG,et al. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N₂ non-small-cell lung cancer:a propensity score matching analysis[J].Clin Lung Cancer,2014,15(5):356-364.DOI:10.1016/j.cllc.2014.05.005.
[23] Zou BW,Xu Y,Li T,et al. A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non–small-cell lung cancer patients with N₂ nodal disease[J].Int J Radiat Oncol Biol Phys,2010,77(2):321-328.DOI:10.1016/j.ijrobp.2009.05.044.
[24] Scotti V,Meattini I,Saieva C,et al. Post-operative radiotherapy in N₂ non-small cell lung cancer:a retrospective analysis of 175 patients[J].Radiother Oncol,2010,96(1):84-88.DOI:10.1016/j.radonc.2010.05.010.
[25] Robinson CG,Patel AP,Bradley JD,et al. Postoperative radiotherapy for pathologic N₂ non–small-cell lung cancer treated with adjuvant chemotherapy:a review of the national cancer data base[J].J Clin Oncol,2015,33(8):870-876.DOI:10.1200/JCO.2014.58.5380.
[26] Feng W,Zhang Q,Fu XL,et al. The emerging outcome of postoperative radiotherapy for stage Ⅲ_A (N₂) non-small cell lung cancer patients:based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume[J].BMC Cancer,2015,15:348.DOI:10.1186/s12885-015-1326-6.
[27] 杜芳芳,袁智勇,王平,等.术后放疗在PN₂期NSCLC中的地位[J].中国肺癌杂志,2009,12(11):1164-1168.DOI:10.3779/j.issn.1009-3419.2009.11.07.
Du FF,Yuan ZY,Wang P,et al. The role of postoperative radiotherapy in stage NSCLC PN₂[J].CHin J Lung Cancer,2009,12(11):1164-1168.DOI:10.3779/j.issn.1009-3419.2009.11.07.
[28] Wisnivesky JP,Halm EA,Bonomi M,et al. Postoperative radiotherapy for elderly patients with stage Ⅲ lung cancer[J].Cancer,2012,118(18):4478-4485.DOI:10.1002/cncr.26585.